Literature DB >> 17403984

Cost-effectiveness of schizophrenia pharmacotherapy.

Stephen B Soumerai, Michael R Law.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403984     DOI: 10.1176/ajp.2007.164.4.678a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  The impact of comparative effectiveness research on health and health care spending.

Authors:  Anirban Basu; Anupam B Jena; Tomas J Philipson
Journal:  J Health Econ       Date:  2011-06-01       Impact factor: 3.883

2.  Comparative effectiveness research for antipsychotic medications: how much is enough?

Authors:  David O Meltzer; Anirban Basu; Herbert Y Meltzer
Journal:  Health Aff (Millwood)       Date:  2009-07-21       Impact factor: 6.301

3.  Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.

Authors:  Anirban Basu; Herbert Y Meltzer
Journal:  J Comp Eff Res       Date:  2012-03       Impact factor: 1.744

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.